Vasista Vittal
- SEC CIK
- 0001652827
No open-market purchases or sales filed in the past year.
Current role at each company
- RGNX REGENXBIO Inc.Chief Financial Officeras of Mar 21, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Vasista Vittal as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 31, 2022 (view filing) | Aug 30 | 1 day | Vasista VittalChief Financial Officer | SSale | −2.40K | $30.24 | −$72.6K | −1.7%135.2K after | |
| Aug 8, 2022 (view filing) | Aug 4-5 | 4 days | Vasista VittalChief Financial Officer | SSale | −17.7K | $35.19 | −$622.1K | −11.4%137.6K after | 2 lots |
| Aug 3, 2022 (view filing) | Aug 1 | 2 days | Vasista VittalChief Financial Officer | SSale | −2.40K | $31.26 | −$75.0K | −1.5%155.2K after | |
| Jul 15, 2022 (view filing) | Jul 13-14 | 2 days | Vasista VittalChief Financial Officer | SSale | −4.80K | $30.01 | −$144.0K | −3.0%157.6K after | 2 lots |